Disney stock dips after proxy sets CEO search timeline, reveals Iger pay and $7 billion buyback goal
24 January 2026
1 min read

Disney stock dips after proxy sets CEO search timeline, reveals Iger pay and $7 billion buyback goal

New York, Jan 23, 2026, 21:41 EST — Market closed

  • Shares of Walt Disney fell close to 2%, ending Friday at $110.98
  • Proxy filing confirms the next CEO will be announced in early 2026; annual meeting scheduled for March 18
  • Investors are eyeing Feb. 2 earnings for fresh insights on streaming, parks, and cash returns

Walt Disney shares (DIS) dropped about 2% on Friday, closing at $110.98. The stock slid $2.23, or 1.97%, by the session’s end. 1

The drop followed Disney’s filing of its annual proxy statement, which outlines shareholder votes for the upcoming annual meeting and provides details on executive compensation and governance. Investors are also gearing up for Feb. 2, when Disney will report fiscal first-quarter results and host its earnings webcast. 2

Chairman James P. Gorman told shareholders the board “currently expect[s] to announce the appointment of the Company’s next CEO in early 2026,” according to the filing. The proxy lists CEO Bob Iger’s fiscal 2025 pay at $45.8 million and notes the CEO-to-median-worker pay ratio at 805-to-1. It also sets a fiscal 2026 share repurchase target of $7 billion, following about $3.5 billion in buybacks in fiscal 2025. Disney has scheduled its annual meeting for March 18 and nominated former Apple COO Jeffrey E. Williams as a new director. 3

Disney lagged behind a U.S. market that barely budged on Friday, with the S&P 500 inching up 0.03% while the Dow slipped 0.58% by the close. “We’re feeling pretty good, but mindful we might have some significant twists and turns,” said Jason Blackwell, chief investment strategist at Focus Partners Wealth. Investors are bracing for a packed earnings calendar and the Fed’s policy meeting on Jan. 27-28. 4

For Disney, the proxy details take on real weight now that the CEO transition is imminent. The company faces choosing a new leader amid ongoing efforts to boost streaming profits without undercutting its film lineup or theme park developments.

The buyback target sends a clear signal but also acts as a limit. It shows confidence in cash flow while raising expectations that might clash with cyclical dips in advertising, parks demand, or content costs.

The proxy season throws a spotlight on the “say-on-pay” vote, a non-binding measure on executive compensation. While a poor outcome won’t directly alter pay, it often pushes boards to rethink their incentives and how they communicate them.

Traders will keep an eye out for follow-on filings, shareholder comments, or any new governance chatter surrounding the CEO search and board composition. Even absent big news, the stock tends to move as investors speculate that a board decision is imminent.

The risks cut both ways. If parks weaken or the advertising market dips, Disney’s margin story could unravel quickly. Share buybacks are usually the first thing to get scaled back.

Disney stock’s next obvious catalyst hits with earnings on Feb. 2, while the annual meeting on March 18 waits in the wings. Investors remain eager for a clearer hint on the timing and identity of Iger’s successor.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Texas Instruments stock price slips to $193 as Wall Street resets targets ahead of earnings
Previous Story

Texas Instruments stock price slips to $193 as Wall Street resets targets ahead of earnings

Merck (MRK) stock price slips into the weekend — what investors watch next week
Next Story

Merck (MRK) stock price slips into the weekend — what investors watch next week

Go toTop